NextPlat (NXPL) Tax Provisions (2017 - 2026)
NextPlat's (NXPL) quarterly Tax Provisions came in at $48000.0 in Q2 2026, up 54.84% year-over-year from $31000.0 in Q2 2025, and up 102.15% quarter-over-quarter from -$2.2 million in Q4 2025.
Analysis
NextPlat (NXPL) Tax Provisions (2017 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Tax Provisions for 8 consecutive years, with $48000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Tax Provisions rose 54.84% year-over-year to $48000.0 in Q2 2026; TTM through Jun 2026 was -$2.2 million, a 32.4% decrease from a year earlier, with the FY2025 full-year figure at -$2.2 million, down 33.43% from the prior year.
- Tax Provisions was $48000.0 for Q2 2026 at NextPlat, up from -$2.2 million in the prior quarter.
- Over five years, Tax Provisions peaked at $52000.0 in Q2 2023 and troughed at -$2.7 million in Q4 2023.
- A 5-year average of -$652307.7 and a median of $20000.0 in 2024 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions jumped 95.65% in 2024 and tumbled 157.78% in 2025, its largest moves.
- Over 5 years, Tax Provisions stood at -$2.0 million in 2022, then tumbled by 37.6% to -$2.7 million in 2023, then surged by 35.6% to -$1.8 million in 2024, then fell by 27.25% to -$2.2 million in 2025, then surged by 102.15% to $48000.0 in 2026.
- The last three Tax Provisions figures came in at $48000.0 (Q2 2026), -$2.2 million (Q4 2025), and -$26000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 121.00 Mn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 54.80 Mn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 12.44 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 1.38 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 88.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 12.40 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -59,000.00 |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 8.20 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 42,000.00 |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 48,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48,000.00 |
| Dec 31, 2025 | -2.24 Mn |
| Sep 30, 2025 | -26,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | 9,000.00 |
| Dec 31, 2024 | -1.76 Mn |
| Sep 30, 2024 | 45,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Dec 31, 2023 | -2.73 Mn |
| Sep 30, 2023 | 23,000.00 |
| Jun 30, 2023 | 52,000.00 |
| Dec 31, 2022 | -1.98 Mn |
| Dec 31, 2019 | 2.00 |
| Sep 30, 2019 | -12.00 |
| Jun 30, 2019 | 757.00 |
| Dec 31, 2018 | -363.00 |
| Sep 30, 2018 | 8,897.00 |
| Dec 31, 2017 | -2,997.00 |
| Sep 30, 2017 | 20,465.00 |